調査レポートカテゴリー： MarketsandMarkets, 世界

Immuno Oncology Assays Market by Product (Consumables, Software), Technology (Immunoassay, Flow Cytometry, PCR, Next Generation Sequencing), Indication (Lung Cancer, Colorectal Cancer), Application (Research, Clinical Diagnostics) - Global Forecast to 2024

免疫腫瘍学におけるアッセイの世界市場予測（～2024年）

◆タイトル：Immuno Oncology Assays Market by Product (Consumables, Software), Technology (Immunoassay, Flow Cytometry, PCR, Next Generation Sequencing), Indication (Lung Cancer, Colorectal Cancer), Application (Research, Clinical Diagnostics) - Global Forecast to 2024
◆商品コード：MD 6896
◆調査・発行会社：MarketsandMarkets
◆発行日：2019年2月20日
◆ページ数：109
◆レポート形式：PDF / 英語
◆納品方法：Eメール（受注後24時間以内）
◆調査対象地域：グローバル
◆産業分野：医療機器
◆販売価格オプション（消費税別）

Single User（1名様閲覧）	USD5,650 ⇒換算￥587,600	見積依頼/購入/質問フォーム
Multi User (Five User)	USD6,650 ⇒換算￥691,600	見積依頼/購入/質問フォーム
Corporate License (全社内共有可)	USD8,150 ⇒換算￥847,600	見積依頼/購入/質問フォーム

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※商品の納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。（振込先：三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。（但し、対応範囲は弊社で判断）
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

免疫腫瘍学におけるアッセイの世界市場は、2018年の29億米ドルから2024年には59億米ドルに達し、この期間中12.7％の年平均成長率で成長すると予測されています。この市場の成長を促す要因として、伝統的な治療法を超える標的治療法の採用の増加、mAbの需要の増加などが考えられます。一方で、免疫療法治療の高コストと製品開発サイクルにおける高い消耗率は、この市場の成長を抑制すると考えられる主な要因です。当調査レポートでは、免疫腫瘍学におけるアッセイの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、製品（消耗品、ソフトウェア）分析、技術（イムノアッセイ、フローサイトメトリー、PCR、次世代シーケンシング）分析、適応症（肺がん、大腸がん）分析、用途（研究、臨床診断）分析、免疫腫瘍学におけるアッセイの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。

“The increasing adoption of targeted therapy over traditional therapy is expected to drive the overall growth of the immuno-oncology assays market.”The immuno-oncology assays market is expected to grow from USD 2.9 billion in 2018 to USD 5.9 billion by 2024, at a CAGR of 12.7% during the forecast period. The immuno-oncology assays market is driven primarily by factors such as the increasing adoption of targeted therapy over traditional therapy and the increasing demand for mAbs. However, the high cost of immunotherapy treatment and the high attrition rate in the product development cycle are the major factors that are expected to restrain the growth of this market during the forecast period.
“The lung cancer segment is expected to grow at the highest CAGR during the forecast period.”

Based on indication, the immuno-oncology assays market is segmented into lung cancer, colorectal cancer, melanoma, bladder cancer, and other cancers. The lung cancer segment is expected to be the fastest-growing segment during the forecast period, as major players are focusing on immuno-oncology research for lung cancer owing to its increasing incidence.
“Asia Pacific projected to grow at the highest CAGR during the forecast period.”
The Asia Pacific is projected to record the highest growth rate during the forecast period. Factors such as growing number of CROs in the region, increasing awareness about early detection of cancer, and the shift of manufacturers’ and suppliers’ focus from developed economies to emerging economies, such as India and China are driving the growth of this regional segment.

In-depth interviews were conducted with Chief Executive Officers (CEOs), marketing directors, other innovation and technology directors, and executives from various key organizations operating in the immuno-oncology assays market.
By Company Type: Tier 1: 18%, Tier 2: 39%, and Tier 3: 43%
By Designation: C-level Executives: 25%, Directors: 20%, and Others: 55%
By Region: North America: 40%, Europe: 27%, APAC: 20%, and RoW: 13%

The immuno-oncology assays market comprises major providers such as Thermo Fischer Scientific (US), Roche Diagnostics (Switzerland), Agilent Technologies (US), and Illumina (US). The study includes an in-depth competitive analysis of these key players in the immuno-oncology assays market, along with their company profiles, recent developments, and key market strategies.
Research Coverage:
The market study covers the immuno-oncology assays market across various segments. It aims at estimating the market size and the growth potential of this market across different segments, on the basis of product, technology, application, indication, and region. The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their product and business offerings, recent developments, and key market strategies.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants in this market and provide information on the closest approximations of the revenue numbers for the overall immuno-oncology assays market and its subsegments. This report will help the stakeholders to understand the competitive landscape, to gain more insights to better position their businesses, and to plan suitable go-to-market strategies. The report will also help the stakeholders to understand the pulse of the market and provide information on key market drivers, restraints, and opportunities.

【レポートの目次】

TABLE OF CONTENTS

1 INTRODUCTION 13
1.1 OBJECTIVES OF THE STUDY 13
1.2 MARKET DEFINITION 13
1.3 MARKET SCOPE 13
1.3.1 MARKETS COVERED 14
1.3.2 YEARS COVERED FOR THE STUDY 14
1.4 CURRENCY 15
1.5 LIMITATIONS 15
1.6 STAKEHOLDERS 15
2 RESEARCH METHODOLOGY 16
2.1 PRIMARY DATA 17
2.1.1 KEY DATA FROM PRIMARY SOURCES 17
2.1.2 KEY INDUSTRY INSIGHTS 18
2.2 SECONDARY DATA 19
2.2.1 KEY DATA FROM SECONDARY SOURCES 19
2.3 MARKET SIZE ESTIMATION 19
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 21
2.4.1 ASSUMPTIONS FOR THE STUDY 22
3 EXECUTIVE SUMMARY 23
4 PREMIUM INSIGHTS 27
4.1 IMMUNO-ONCOLOGY ASSAYS: MARKET OVERVIEW 27
4.2 NORTH AMERICA: IMMUNO-ONCOLOGY ASSAYS MARKET,
BY PRODUCT AND COUNTRY (2018) 28
4.3 IMMUNO-ONCOLOGY ASSAYS MARKET, BY APPLICATION (2018 VS. 2024) 28
4.4 IMMUNO-ONCOLOGY ASSAYS MARKET, BY TECHNOLOGY (2018 VS. 2024) 29
4.5 GEOGRAPHICAL SNAPSHOT OF THE IMMUNO-ONCOLOGY ASSAYS MARKET 29
5 MARKET OVERVIEW 30
5.1 INTRODUCTION 30
5.2 MARKET DYNAMICS 30
5.2.1 DRIVERS 31
5.2.1.1 Rising incidence of cancer and increasing adoption of targeted therapy 31
5.2.2 RESTRAINTS 31
5.2.2.1 Unfavorable regulatory and reimbursement scenario 31
5.2.2.2 High amount of capital investments and low benefit-cost ratio 32
5.2.3 OPPORTUNITIES 32
5.2.3.1 Companion diagnostics 32
6 IMMUNO-ONCOLOGY ASSAYS MARKET, BY PRODUCT 33
6.1 INTRODUCTION 34
6.2 CONSUMABLES 34
6.2.1 CONSUMABLES SEGMENT WILL CONTINUE TO DOMINATE THE IMMUNO-ONCOLOGY ASSAYS MARKET DURING THE FORECAST PERIOD 34
6.3 SOFTWARE 35
6.3.1 THE NEED TO DELIVER ACCURATE AND TIMELY ANALYSIS OF DIAGNOSTIC TESTS HAS RESULTED IN THE INCREASED ADOPTION OF SOFTWARE 35
7 IMMUNO-ONCOLOGY ASSAYS MARKET, BY TECHNOLOGY 37
7.1 INTRODUCTION 38
7.2 PCR 38
7.2.1 EMERGENCE OF ADVANCED PCR TECHNOLOGIES TO SUPPORT MARKET GROWTH 38
7.3 IMMUNOASSAY 39
7.3.1 IMMUNOASSAYS HAVE THE POTENTIAL TO REDUCE CANCER MORTALITY RATE BY FACILITATING THE DIAGNOSIS OF CANCER IN THE EARLY STAGE 39
7.4 NGS 41
7.4.1 NGS SEGMENT TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD 41
7.5 FLOW CYTOMETRY 42
7.5.1 FLOW CYTOMETRY PLAYS A CRITICAL ROLE IN CLINICAL RESEARCH STUDIES 42
7.6 OTHER TECHNOLOGIES 43
8 IMMUNO-ONCOLOGY ASSAYS MARKET, BY INDICATION 45
8.1 INTRODUCTION 46
8.2 LUNG CANCER 46
8.2.1 INCREASING R&D ACTIVITIES ON LUNG IMMUNO-ONCOLOGY ASSAYS IS A KEY MARKET DRIVER 46
8.3 COLORECTAL CANCER 48
8.3.1 HIGH SUCCESS RATE OF IMMUNO-ONCOLOGY ASSAYS IN CRC TREATMENT DECISIONS TO DRIVE MARKET GROWTH 48
8.4 MELANOMA 49
8.4.1 GROWING CASES OF MELANOMA TO DRIVE MARKET GROWTH 49
8.5 BLADDER CANCER 50
8.5.1 BLADDER CANCER SEGMENT TO WITNESS SLOWER GROWTH OWING TO THE LIMITED ADOPTION OF IMMUNO-ONCOLOGY ASSAYS 50
8.6 OTHER CANCERS 51

9 IMMUNO-ONCOLOGY ASSAYS MARKET, BY APPLICATION 52
9.1 INTRODUCTION 53
9.2 RESEARCH APPLICATIONS 53
9.2.1 RISING PROMINENCE OF BIOMARKER-BASED DRUG DEVELOPMENT AND CLINICAL TRIALS TO DRIVE THE RESEARCH APPLICATIONS MARKET 53
9.3 CLINICAL DIAGNOSTICS 54
9.3.1 BENEFITS OF IMMUNO-ONCOLOGY ASSAYS ARE DRIVING ITS ADOPTION IN CLINICAL DIAGNOSTICS 54
10 IMMUNO-ONCOLOGY ASSAYS MARKET, BY REGION 56
10.1 INTRODUCTION 57
10.2 NORTH AMERICA 58
10.2.1 US 61
10.2.1.1 Increasing demand for immunotherapy medicine forms a key driver of market growth in the US 61
10.2.2 CANADA 63
10.2.2.1 High burden of cancer to drive the demand for immuno-oncology assays 63
10.3 EUROPE 65
10.3.1 RISING FOCUS ON BIOMARKER DEVELOPMENT IN SEVERAL EU COUNTRIES TO SUPPORT MARKET GROWTH 65
10.4 ASIA PACIFIC 67
10.4.1 INCREASING DEMAND FOR BETTER HEALTHCARE SERVICES IN DEVELOPING ECONOMIES WILL CONTRIBUTE TO MARKET GROWTH 67
10.5 REST OF THE WORLD 70
11 COMPETITIVE LANDSCAPE 73
11.1 OVERVIEW 73
11.2 VENDOR BENCHMARKING 73
11.3 COMPETITIVE LEADERSHIP MAPPING 74
11.3.1 VISIONARY LEADERS 74
11.3.2 INNOVATORS 74
11.3.3 DYNAMIC DIFFERENTIATORS 74
11.3.4 EMERGING COMPANIES 74
11.4 MARKET RANKING ANALYSIS, 2017 76
11.5 COMPETITIVE SITUATION AND TRENDS 77
11.5.1 COLLABORATIONS 77
11.5.2 PRODUCT LAUNCHES 77
11.5.3 ACQUISITIONS 78
11.5.4 EXPANSIONS 78

12 COMPANY PROFILES 79
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
12.1 THERMO FISHER SCIENTIFIC, INC. 79
12.2 ROCHE DIAGNOSTICS 82
12.3 AGILENT TECHNOLOGIES, INC. 84
12.4 ILLUMINA, INC. 86
12.5 NANOSTRING TECHNOLOGIES, INC. 88
12.6 SARTORIUS AG 90
12.7 FOUNDATION MEDICINE 92
12.8 HTG MOLECULAR DIAGNOSTICS, INC. 93
12.9 QIAGEN 95
12.10 MERCK 97
12.11 PERKINELMER 99

*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.
13 APPENDIX 101
13.1 INSIGHTS OF INDUSTRY EXPERTS 101
13.2 DISCUSSION GUIDE 102
13.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 105
13.4 AVAILABLE CUSTOMIZATIONS 107
13.5 RELATED REPORTS 107
13.6 AUTHOR DETAILS 108

LIST OF TABLES

TABLE 1 IMMUNO-ONCOLOGY ASSAYS MARKET, BY PRODUCT, 2016–2024 (USD MILLION) 34
TABLE 2 IMMUNO-ONCOLOGY ASSAYS MARKET FOR CONSUMABLES, BY REGION,
2016–2024 (USD MILLION) 34
TABLE 3 NORTH AMERICA: IMMUNO-ONCOLOGY ASSAYS MARKET FOR CONSUMABLES,
BY COUNTRY, 2016–2024 (USD MILLION) 35
TABLE 4 IMMUNO-ONCOLOGY ASSAYS MARKET FOR SOFTWARE, BY REGION,
2016–2024 (USD MILLION) 36
TABLE 5 NORTH AMERICA: IMMUNO-ONCOLOGY ASSAYS MARKET FOR SOFTWARE,
BY COUNTRY, 2016–2024 (USD MILLION) 36
TABLE 6 IMMUNO-ONCOLOGY ASSAYS MARKET, BY TECHNOLOGY,
2016–2024 (USD MILLION) 38
TABLE 7 IMMUNO-ONCOLOGY ASSAYS MARKET FOR PCR, BY REGION,
2016–2024 (USD MILLION) 39
TABLE 8 NORTH AMERICA: IMMUNO-ONCOLOGY ASSAYS MARKET FOR PCR,
BY COUNTRY, 2016–2024 (USD MILLION) 39
TABLE 9 IMMUNO-ONCOLOGY ASSAYS MARKET FOR IMMUNOASSAY,
BY REGION, 2016–2024 (USD MILLION) 40
TABLE 10 NORTH AMERICA: IMMUNO-ONCOLOGY ASSAYS MARKET FOR IMMUNOASSAY,
BY COUNTRY, 2016–2024 (USD MILLION) 40
TABLE 11 IMMUNO-ONCOLOGY ASSAYS MARKET FOR NGS, BY REGION,
2016–2024 (USD MILLION) 41
TABLE 12 NORTH AMERICA: IMMUNO-ONCOLOGY ASSAYS MARKET FOR NGS,
BY COUNTRY, 2016–2024 (USD MILLION) 42
TABLE 13 IMMUNO-ONCOLOGY ASSAYS MARKET FOR FLOW CYTOMETRY,
BY REGION, 2016–2024 (USD MILLION) 42
TABLE 14 NORTH AMERICA: IMMUNO-ONCOLOGY ASSAYS MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2016–2024 (USD MILLION) 43
TABLE 15 IMMUNO-ONCOLOGY ASSAYS MARKET FOR OTHER TECHNOLOGIES,
BY REGION, 2016–2024 (USD MILLION) 43
TABLE 16 NORTH AMERICA: IMMUNO-ONCOLOGY ASSAYS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2016–2024 (USD MILLION) 44
TABLE 17 IMMUNO-ONCOLOGY ASSAYS MARKET, BY INDICATION,
2016–2024 (USD MILLION) 46
TABLE 18 IMMUNO-ONCOLOGY ASSAYS MARKET FOR LUNG CANCER, BY REGION,
2016–2024 (USD MILLION) 47
TABLE 19 NORTH AMERICA: IMMUNO-ONCOLOGY ASSAYS MARKET FOR LUNG CANCER,
BY COUNTRY, 2016–2024 (USD MILLION) 47
TABLE 20 IMMUN0-ONCOLOGY ASSAYS MARKET FOR COLORECTAL CANCER, BY REGION, 2016–2024 (USD MILLION) 48
TABLE 21 NORTH AMERICA: IMMUN0-ONCOLOGY ASSAYS MARKET FOR COLORECTAL CANCER, BY COUNTRY, 2016–2024 (USD MILLION) 48
TABLE 22 IMMUN0-ONCOLOGY ASSAYS MARKET FOR MELANOMA, BY REGION,
2016–2024 (USD MILLION) 49
TABLE 23 NORTH AMERICA: IMMUN0-ONCOLOGY ASSAYS MARKET FOR MELANOMA,
BY COUNTRY, 2016–2024 (USD MILLION) 49
TABLE 24 IMMUN0-ONCOLOGY ASSAYS MARKET FOR BLADDER CANCER, BY REGION,
2016–2024 (USD MILLION) 50
TABLE 25 NORTH AMERICA: IMMUN0-ONCOLOGY ASSAYS MARKET FOR BLADDER CANCER, BY COUNTRY, 2016–2024 (USD MILLION) 50
TABLE 26 IMMUNO-ONCOLOGY ASSAYS MARKET FOR OTHER CANCERS, BY REGION,
2016–2024 (USD MILLION) 51
TABLE 27 NORTH AMERICA: IMMUNO-ONCOLOGY ASSAYS MARKET FOR OTHER CANCERS,
BY COUNTRY, 2016–2024 (USD MILLION) 51
TABLE 28 IMMUNO-ONCOLOGY ASSAYS MARKET, BY APPLICATION,
2016–2024 (USD MILLION) 53
TABLE 29 IMMUNO-ONCOLOGY ASSAYS MARKET FOR RESEARCH APPLICATIONS,
BY REGION, 2016–2024 (USD MILLION) 54
TABLE 30 NORTH AMERICA: IMMUNO-ONCOLOGY ASSAYS MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2016–2024 (USD MILLION) 54
TABLE 31 IMMUNO-ONCOLOGY ASSAYS MARKET FOR APPLICATIONS, BY CLINICAL DIAGNOSTICS, 2016–2024 (USD MILLION) 55
TABLE 32 NORTH AMERICA: IMMUNO-ONCOLOGY ASSAYS MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2016–2024 (USD MILLION) 55
TABLE 33 IMMUNO-ONCOLOGY ASSAYS MARKET, BY REGION, 2016–2024 (USD MILLION) 57
TABLE 34 NORTH AMERICA: IMMUNO-ONCOLOGY ASSAYS MARKET, BY COUNTRY,
2016–2024 (USD MILLION) 59
TABLE 35 NORTH AMERICA: IMMUNO-ONCOLOGY ASSAYS MARKET, BY PRODUCT,
2016–2024 (USD MILLION) 59
TABLE 36 NORTH AMERICA: IMMUNO-ONCOLOGY ASSAYS MARKET, BY TECHNOLOGY,
2016–2024 (USD MILLION) 59
TABLE 37 NORTH AMERICA: IMMUNO-ONCOLOGY ASSAYS MARKET, BY INDICATION,
2016–2024 (USD MILLION) 60
TABLE 38 NORTH AMERICA: IMMUNO-ONCOLOGY ASSAYS MARKET, BY APPLICATION,
2016–2024 (USD MILLION) 60
TABLE 39 US: IMMUNO-ONCOLOGY ASSAYS MARKET, BY PRODUCT,
2016–2024 (USD MILLION) 61
TABLE 40 US: IMMUNO-ONCOLOGY ASSAYS MARKET, BY TECHNOLOGY,
2016–2024 (USD MILLION) 61
TABLE 41 US: IMMUNO-ONCOLOGY ASSAYS MARKET, BY INDICATION,
2016–2024 (USD MILLION) 62
TABLE 42 US: IMMUNO-ONCOLOGY ASSAYS MARKET, BY APPLICATION,
2016–2024 (USD MILLION) 62
TABLE 43 CANADA: IMMUNO-ONCOLOGY ASSAYS MARKET, BY PRODUCT,
2016–2024 (USD MILLION) 63
TABLE 44 CANADA: IMMUNO-ONCOLOGY ASSAYS MARKET, BY TECHNOLOGY,
2016–2024 (USD MILLION) 63
TABLE 45 CANADA: IMMUNO-ONCOLOGY ASSAYS MARKET, BY INDICATION,
2016–2024 (USD MILLION) 64
TABLE 46 CANADA: IMMUNO-ONCOLOGY ASSAYS MARKET, BY APPLICATION,
2016–2024 (USD MILLION) 64
TABLE 47 EUROPE: IMMUNO-ONCOLOGY ASSAYS MARKET, BY PRODUCT,
2016–2024 (USD MILLION) 65
TABLE 48 EUROPE: IMMUNO-ONCOLOGY ASSAYS MARKET, BY TECHNOLOGY,
2016–2024 (USD MILLION) 66
TABLE 49 EUROPE: IMMUNO-ONCOLOGY ASSAYS MARKET, BY INDICATION,
2016–2024 (USD MILLION) 66
TABLE 50 EUROPE: IMMUNO-ONCOLOGY ASSAYS MARKET, BY APPLICATION,
2016–2024 (USD MILLION) 67
TABLE 51 APAC: IMMUNO-ONCOLOGY ASSAYS MARKET, BY PRODUCT,
2016–2024 (USD MILLION) 68
TABLE 52 APAC: IMMUNO-ONCOLOGY ASSAYS MARKET, BY TECHNOLOGY,
2016–2024 (USD MILLION) 69
TABLE 53 APAC: IMMUNO-ONCOLOGY ASSAYS MARKET, BY INDICATION,
2016–2024 (USD MILLION) 69
TABLE 54 APAC: IMMUNO-ONCOLOGY ASSAYS MARKET, BY APPLICATION,
2016–2024 (USD MILLION) 70
TABLE 55 ROW: IMMUNO-ONCOLOGY ASSAYS MARKET, BY PRODUCT,
2016–2024 (USD MILLION) 70
TABLE 56 ROW: IMMUNO-ONCOLOGY ASSAYS MARKET, BY TECHNOLOGY,
2016–2024 (USD MILLION) 71
TABLE 57 ROW: IMMUNO-ONCOLOGY ASSAYS MARKET, BY INDICATION,
2016–2024 (USD MILLION) 71
TABLE 58 ROW: IMMUNO-ONCOLOGY ASSAYS MARKET, BY APPLICATION,
2016–2024 (USD MILLION) 72
TABLE 59 VENDOR BENCHMARKING BY GROWTH STRATEGY 73
TABLE 60 COLLABORATIONS, 2016–2018 77
TABLE 61 PRODUCT LAUNCHES, 2016–2018 77
TABLE 62 ACQUISITIONS, 2016-2018 78
TABLE 63 EXPANSIONS, 2015 TO 2018 78

LIST OF FIGURES

FIGURE 1 RESEARCH DESIGN 16
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION,
AND REGION 18
FIGURE 3 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH 20
FIGURE 4 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 20
FIGURE 5 DATA TRIANGULATION 21
FIGURE 6 IMMUNO-ONCOLOGY ASSAYS MARKET, BY APPLICATION,
2018 VS. 2024 (USD MILLION) 23
FIGURE 7 IMMUNO-ONCOLOGY ASSAYS MARKET, BY PRODUCT,
2018 VS. 2024 (USD MILLION) 24
FIGURE 8 IMMUNO-ONCOLOGY ASSAYS MARKET, BY INDICATION,
2018 VS. 2024 (USD MILLION) 24
FIGURE 9 IMMUNO-ONCOLOGY ASSAYS MARKET, BY TECHNOLOGY,
2018 VS. 2024 (USD MILLION) 25
FIGURE 10 GEOGRAPHICAL SNAPSHOT OF THE IMMUNO-ONCOLOGY ASSAYS MARKET 25
FIGURE 11 INCREASING ADOPTION OF TARGETED THERAPY OVER TRADITIONAL
THERAPY IS A KEY DRIVER FOR THE IMMUNO-ONCOLOGY ASSAYS MARKET 27
FIGURE 12 CONSUMABLES SEGMENT TO ACCOUNT FOR LARGEST SHARE IN NORTH AMERICAN IMMUNO-ONCOLOGY ASSAYS MARKET 28
FIGURE 13 RESEARCH APPLICATIONS TO CONTINUE TO DOMINATE THE IMMUNO-ONCOLOGY ASSAYS MARKET IN 2024 28
FIGURE 14 PCR SEGMENT WILL CONTINUE TO DOMINATE THE IMMUNO-ONCOLOGY ASSAYS MARKET IN 2024 29
FIGURE 15 APAC WILL BE THE FASTEST-GROWING MARKET FROM 2018 TO 2024 29
FIGURE 16 IMMUNO-ONCOLOGY ASSAYS MARKET: DRIVERS, RESTRAINTS, AND OPPORTUNITIES 30
FIGURE 17 NORTH AMERICA: IMMUNO-ONCOLOGY ASSAYS MARKET SNAPSHOT 58
FIGURE 18 ASIA PACIFIC: IMMUNO-ONCOLOGY ASSAYS MARKET SNAPSHOT 68
FIGURE 19 IMMUNO-ONCOLOGY ASSAYS MARKET (GLOBAL), COMPETITIVE LEADERSHIP MAPPING, 2017 75
FIGURE 20 RANK OF COMPANIES IN THE GLOBAL IMMUNO-ONCOLOGY
ASSAYS MARKET, 2017 76
FIGURE 21 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2017) 79
FIGURE 22 ROCHE DIAGNOSTICS: COMPANY SNAPSHOT (2017) 82
FIGURE 23 AGILENT TECHNOLOGIES: COMPANY SNAPSHOT (2017) 84
FIGURE 24 ILLUMINA: COMPANY SNAPSHOT (2017) 86
FIGURE 25 NANOSTRING TECHNOLOGIES: COMPANY SNAPSHOT (2017) 88
FIGURE 26 SARTORIUS AG: COMPANY SNAPSHOT (2017) 90
FIGURE 27 HTG MOLECULAR DIAGNOSTICS: COMPANY SNAPSHOT (2017) 93
FIGURE 28 QIAGEN: COMPANY SNAPSHOT (2017) 95
FIGURE 29 MERCK: COMPANY SNAPSHOT (2017) 97
FIGURE 30 PERKINELMER: COMPANY SNAPSHOT (2017) 99

★調査レポート[免疫腫瘍学におけるアッセイの世界市場予測（～2024年）] ( Immuno Oncology Assays Market by Product (Consumables, Software), Technology (Immunoassay, Flow Cytometry, PCR, Next Generation Sequencing), Indication (Lung Cancer, Colorectal Cancer), Application (Research, Clinical Diagnostics) - Global Forecast to 2024 / MD 6896) 販売に関する免責事項

[免疫腫瘍学におけるアッセイの世界市場予測（～2024年）] ( Immuno Oncology Assays Market by Product (Consumables, Software), Technology (Immunoassay, Flow Cytometry, PCR, Next Generation Sequencing), Indication (Lung Cancer, Colorectal Cancer), Application (Research, Clinical Diagnostics) - Global Forecast to 2024 / MD 6896) についてEメールでお問い合わせ

◆関連調査資料◆

分子品質管理の世界市場予測（～2024年）
MD 6900 / MarketsandMarkets / 2019年2月20日 / 分子品質管理の世界市場は、2018年の1億3,200万米ドルから2024年には2億3,700万米ドルに達し、この期間中10.2％の年平均成長率で成長すると予測されています。この市場の成長を促す要因として、サードパーティの品質管理の採用の増加、認定臨床検査機関の数の増加、および外部品質評価サポートに対する需要の高まりなどが考えられます。一方で、品質管理プロセスに伴う高コスト、病院や研究機関における予算上の制約、そして分子検査に関連する不利な払い戻し条件により、市場の成長が抑制される可能性があります。当調査レポートでは、分子品質管理の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、製品（独立型、ツール固有）分析、検体の種類（単一検体、複数検体）分析、用途（感染症）分析、エンドユーザー（IVDメーカー、研究機関）分析、分子品質管理の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...“The rising adoption of third-party quality controls is expected to drive the overall growth of the molecular quality controls market.”The molecular quality controls market is expected to grow from USD 132 million in 2018 to USD 237 million by 2024, at a CAGR of 10.2% during the forecast period. The molecular quality controls market is driven primarily by the rising adoption of third-party quality controls, increasing number of accredited clinical laboratories, and the rising demand for external quality assessment support. However, the high costs involved in the quality control process, budget constraints in hospitals and laboratories, and the unfavorable reimbursement...

密封式薬剤移送システムの世界市場予測（～2024年）
MD 6925 / MarketsandMarkets / 2019年2月26日 / 密封式薬剤移送システムの世界市場は、2019年の3億9,000万米ドルから2024年には9億8,200万米ドルに達し、この期間中20.3％の年平均成長率で成長すると予測されています。この市場の成長を促す要因として、がんの発生率の増加、腫瘍治療薬の承認数の増加、細胞障害性薬物または抗悪性腫瘍薬の悪影響を取り除くことを目的とした密封式薬剤移送システムの使用増加、危険な薬物の安全な取り扱いと使用に関する規制ガイドラインの改善などが考えられます。一方で、CSTD導入コストが高価であること、医療保険払い戻しの環境が整っていないこと、ならびに発展途上国において規制ガイドラインが遵守されていないことにより、市場の成長が抑制されています。当調査レポートでは、密封式薬剤移送システムの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、閉鎖機構（ルアーロック、プッシュトゥターン）分析、種類（メンブレン間、ニードルレス）分析、技術（ダイアフラム、区画化、空気ろ過）分析、コンポーネント分析、密封式薬剤移送システムの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...“The global closed system transfer devices Market is projected to grow at a CAGR of 20.3%.”The closed system transfer devices market is projected to reach USD 982 million by 2024 from USD 390 million in 2019, at a CAGR of 20.3%. Factors such as the rising incidence of cancer, an increasing number of oncology drug approvals, increasing use of closed system transfer devices to combat the harmful effects of cytotoxic or antineoplastic drugs, and improving regulatory guidelines regarding the safe handling and use of hazardous drugs are driving the growth of the closed system transfer devices market. However, market growth...

医薬品有効成分（API）の世界市場予測（～2024年）
PH 1262 / MarketsandMarkets / 2019年1月7日 / 医薬品有効成分（API）の世界市場は、2019年の1,822億米ドルから2024年には2,452億米ドルに達し、この期間中6.1％の年平均成長率で成長すると予測されています。この市場の成長を促す要因として、慢性疾患の発生率の増加、ジェネリック医薬品の重要性の高まり、およびバイオ医薬品に対する理解の増加が考えられます。特に、商用における使用が主な用途です。航空機への複合材料の使用の増加と機体数の増加は、今後5年間でこの市場の成長を促進すると予想されます。一方で、市場に不利な医薬品価格管理政策と偽造医薬品の蔓延は、この市場の成長を抑制すると予想されます。当調査レポートでは、医薬品有効成分（API）の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、種類別（革新的API、ジェネリックAPI）分析、メーカー別（キャプティブ、マーチャント）分析、合成別（合成、バイオテクノロジ）分析、製品別（mAb、ホルモン、バイオシミラー）分析、医薬品有効成分（API）の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...“Increasing incidence of chronic diseases and technological advancements in API manufacturing are expected to drive the overall growth of the global APIs market.”The global APIs market is estimated to reach USD 245.2 billion by 2024 from USD 182.2 billion in 2019, at a CAGR of 6.1% during the forecast period. The increasing incidence of chronic diseases, growing importance of generics, and the increasing uptake of biopharmaceuticals are some of the major factors driving the growth of the global APIs market. On the other hand, the unfavorable drug price control policies across various countries and the increasing penetration of counterfeit drugs...

免疫沈降（IP）の世界市場予測（～2024年）
BT 6910 / MarketsandMarkets / 2019年2月20日 / 免疫沈降の世界市場は、2018年の5億6,000万米ドルから2024年には7億5,000万米ドルに達し、この期間中5.0％の年平均成長率で成長すると予測されています。この市場の成長を促す要因として、ライフサイエンス業界における研究活動の増加と自己免疫疾患に関連する抗原を同定する（疾患メカニズムを理解し、これらの疾患を標的とする関連薬物を開発するための抗原抗体反応を用いる）必要性の高まりが考えられます。一方で、タンパク質精製のための代替技術の存在は市場の成長を妨げる可能性があります。当調査レポートでは、免疫沈降（IP）の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、製品（キット、試薬）分析、種類（単独IP、共免疫沈降、ChIP）分析、エンドユーザー（学術機関、研究機関、製薬会社・バイオテクノロジー企業）分析、免疫沈降（IP）の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...“Increasing research activity in the life sciences industry is expected to drive the overall growth of the immunoprecipitation market.”The immunoprecipitation market is projected to reach USD 750 million by 2024 from USD 560 million in 2018, at CAGR of 5.0% during forecast period. The growth of this market is majorly driven by the increasing number of research activities in the life sciences industry and the growing need to identify antigens associated with autoimmune diseases (through antigen-antibody interaction to understand disease mechanisms and develop relevant drugs targeting these diseases). However, the presence of alternative technologies for protein purification is expected to...

標本回収の世界市場予測（～2024年）
MD 6901 / MarketsandMarkets / 2019年2月20日 / 標本回収の世界市場は、2019年の2億3,000万米ドルから2024年には2億9,000万米ドルに達し、この期間中4.7％の年平均成長率で成長すると予測されています。この市場の成長を促す要因として、外科的治療および腹腔鏡手術といった身体から標本を除去する必要がある疾患の蔓延、さらには新興国におけるヘルスケア支出の増加などが考えられます。当調査レポートでは、標本回収の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、バッグサイズ（5mm、10mm、15mm、25mm）分析、種類（取り外し可能、取り外し不可）分析、用途（婦人科、泌尿器科、消化器外科）分析、エンドユーザー（病院、通院外科診療所、老人ホーム）分析、標本回収の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...“Specimen retrieval systems market to register a CAGR of 4.7% from 2019 to 2024.” The specimen retrieval systems market is projected to reach USD 290 million by 2024 from USD 230 million in 2019, at a CAGR of 4.7% during the forecast period. Growth in this market is mainly driven by the increasing prevalence of diseases requiring surgical treatment and the removal of specimens from the body, especially laparoscopic procedures. Emerging economies with growing healthcare expenditures are also expected to provide opportunities for the growth of the market. “Non-detachable specimen retrieval systems accounted for a significant share of the market...

結紮デバイスの世界市場予測（～2024年）
MD 6904 / MarketsandMarkets / 2019年2月20日 / 結紮デバイスの世界市場は、2019年の8億7,600万米ドルから2024年には11億8,900万米ドルに達し、この期間中6.3％の年平均成長率で成長すると予測されています。この市場の成長を促す要因として、低侵襲手術（MIS）を必要とする疾患の罹患率の増加、ならびに新興国におけるヘルスケア支出の増加などが考えられます。当調査レポートでは、結紮デバイスの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、製品（ハンドヘルド式機器、関連部品）分析、処置（低侵襲手術、開腹手術）分析、用途（婦人科、GIT、心臓血管、泌尿器科）分析、エンドユーザー（病院、老人ホーム）分析、結紮デバイスの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...“Ligation devices market to register a CAGR of 6.3% from 2019 to 2024” The ligation devices market is projected to reach USD 1,189 million by 2024 from USD 876 million in 2019, at a CAGR of 6.3% during the forecast period. Growth in this market is mainly driven by the increasing prevalence of diseases requiring surgical treatment, especially minimally invasive surgery (MIS). Emerging economies with growing healthcare expenditures are also expected to provide opportunities for the growth of the market. “Accessories accounted for a significant share of the market in 2018” By product, the ligation devices market is segmented into...

X線検出器の世界市場予測（～2024年）
MD 3056 / MarketsandMarkets / 2019年2月4日 / X線検出器の世界市場は、2019年の28億米ドルから2024年には38億米ドルに達し、この期間中6.1％の年平均成長率で成長すると予測されています。この市場の成長を促す要因として、デジタル画像処理技術への官民投資の拡大、デジタル検出器の低価格化と利点、およびアナログX線に対する医療費償還の削減などが考えられます。特に、ワイヤレスX線検出器の導入、発展途上国でのメディカルツーリズムの成長、そして新興市場は、市場プレーヤーに幅広い成長機会を提供すると期待されています。一方で、デジタルX線システムは高額になることから、この市場の成長を抑制する主な要因となることが考えられます。当調査レポートでは、X線検出器の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、種類別（FPD、CSI、Gadox、CCD、ラインスキャン）分析、パネル別（小型、大型）分析、ポータビリティ別（据置型、ポータブル）分析、システム別（新規、レトロフィット）分析、X線検出器の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...“Global X-ray detectors market projected to grow at a CAGR of 6.1%.”The X-ray detectors market is projected to reach USD 3.8 billion by 2024 from USD 2.8 billion in 2019, at a CAGR of 6.1%. Factors such as growing public and private investments in digital imaging technologies, declining prices and benefits offered by digital detectors, and reimbursement cuts for analog X-rays are driving the growth of the X-ray detectors market. The introduction of wireless X-ray detectors, growing medical tourism in developing countries, and the emerging markets are expected to provide a wide range of growth opportunities for players in the...

温度監視システムの世界市場予測（～2024年）
AST 6931 / MarketsandMarkets / 2019年2月26日 / 温度監視システムの世界市場は、2019年の45億米ドルから2024年には54億米ドルに達し、この期間中3.9％の年平均成長率で成長すると予測されています。この市場の成長を促す要因として、さまざまな業界における製造活動の活発化、製品品質を保証するための厳格な規制（特に食品・飲料および製薬分野）、技術の進歩、患者数の増加、および罹患率の増加などが考えられます。一方で、高度な温度監視システムは高価格となり、この市場の成長を抑制すると予想されます。当調査レポートでは、温度監視システムの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、製品（モニター、ストリップ、ハンドヘルド、ワイヤレス、高温計、赤外線、カメラ、光ファイバー）分析、用途（保冷、温室、ライフサイエンス、患者）分析、エンドユーザー分析、温度監視システムの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...“The global temperature monitoring systems market to register a CAGR of 3.9% from 2018 to 2024.” The global temperature monitoring systems market is projected to reach USD 5.4 billion by 2024 from USD 4.5 billion in 2019, at a CAGR of 3.9% during the forecast period. Factors such as rising manufacturing activity across a range of industries, stringent regulations to ensure product quality (particularly in the food & beverage and pharmaceutical sectors), technological advancements, the growing patient population, and increasing disease prevalence are expected to propel the growth of this market. However, the high prices of advanced temperature monitoring systems...

配送ロボットの世界市場予測（～2024年）
SE 6875 / MarketsandMarkets / 2019年1月29日 / 配送ロボットの世界市場は、2018年の119億米ドルから2024年には340億米ドルに達し、この期間中19.15％の年平均成長率で成長すると予測されています。世界市場には多数の巨大なオンライン小売業者が存在し、さらに新たな小売業者も続々と参入しています。世界中で、高い割引率やスムーズな配達の恩恵を受けることが可能になりオンラインショッピングが選好されるようになったため、一部の巨大なオフライン小売業者でさえオンラインへと移行しています。電子商取引に自律型配送ロボットを導入することで、顧客はより低いコストでより大きな利便性を得られるだけでなく、競争環境も大幅に変わりつつあります。つまり、ラストマイル配送のコスト削減は、市場の成長を牽引する重要な要素の1つと言えます。当調査レポートでは、配送ロボットの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、積載量別（10kg以下、10.01〜50.00kg、50kg超）分析、コンポーネント別（LiDARセンサー、制御システム）分析、ホイール数別（3、4、6）分析、エンドユーザー産業別（食品・飲料、小売）分析、配送ロボットの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...“The delivery robots market projected to grow at a CAGR of 19.15% during 2018–2024” The delivery robots market is expected to grow from USD 11.9 billion in 2018 to USD 34.0 billion by 2024, at a CAGR of 19.15% during the forecast period. There are numerous giant online retailers in the global market, along with the emerging ones. Even some giant offline retailers are going online because people all over the world have started preferring online shopping owing to the huge discount and smooth delivery at their doorstep. The introduction of autonomous delivery robots in e-commerce will not only give...

◆H&Iグローバルリサーチ株式会社のお客様（例）◆